Abstract
(-)-Epigallocatechin-3-O-gallate (EGCG) exhibits anti-tumor activity mediated via the 67-kDa laminin receptor (67LR). In this study, we found that 67LR protein levels are reduced by exposure to low O(2) levels (5%), without affecting the expression of HIF-1α. We also found that EGCG-induced anti-cancer activity is abrogated under low O(2) levels (5%) in various cancer cells. Notably, treatment with the proteasome inhibitor, prevented down-regulation of 67LR and restored sensitivity to EGCG under 5% O(2). In summary, 67LR expression is highly sensitive to O(2) partial pressure, and the activity of EGCG can be regulated in cancer cells by O(2) partial pressure.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents, Phytogenic / pharmacology*
-
Base Sequence
-
Catechin / analogs & derivatives*
-
Catechin / pharmacology
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
DNA Primers / genetics
-
HeLa Cells
-
Hep G2 Cells
-
Humans
-
Hypoxia / metabolism
-
Hypoxia / pathology
-
Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
-
Melanoma, Experimental / drug therapy
-
Melanoma, Experimental / genetics
-
Melanoma, Experimental / metabolism
-
Melanoma, Experimental / pathology
-
Mice
-
Oxygen / metabolism*
-
Proteasome Inhibitors / pharmacology
-
Reactive Oxygen Species / metabolism
-
Receptors, Laminin / chemistry
-
Receptors, Laminin / genetics
-
Receptors, Laminin / metabolism*
-
Ubiquitination
Substances
-
Antineoplastic Agents, Phytogenic
-
DNA Primers
-
Hif1a protein, mouse
-
Hypoxia-Inducible Factor 1, alpha Subunit
-
Proteasome Inhibitors
-
Reactive Oxygen Species
-
Receptors, Laminin
-
Catechin
-
epigallocatechin gallate
-
Oxygen